Status:

RECRUITING

Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study

Lead Sponsor:

Sebastian Zschaeck

Collaborating Sponsors:

Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany

Conditions:

Esophagus Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This trial on biomarker validation investigates the use of innovative re-staging FDG-PET parameters to detect highly chemoradiation (CRT) sensitive squamous cell carcinomas of the esophagus (SCEC) at ...

Detailed Description

This trial on biomarker validation investigates the use of innovative re-staging FDG-PET parameters to detect highly chemoradiation (CRT) sensitive squamous cell carcinomas of the esophagus (SCEC) at ...

Eligibility Criteria

Inclusion

  • patients with squamous cell, undifferentiated or adenocarcinoma of the esophagus, UICC stage II-IVA (maximum T4a)
  • ECOG performace status 0-2
  • Complete clinical staging, including, esophagogastroscopy, EUS, CT neck/thorax/abdomen and adequate pulmonary function.
  • Adequate hematological, renal, hepatic and pulmonary functions defined as:
  • granulocytes ≥ 1.5 x 109/l platelets ≥ 100 x 109/l total bilirubin ≤ 1.5 x upper normal limit creatinine ≤ 120 μmol/L FEV1 ≥ 1.5 L
  • Written, voluntary informed consent
  • Willingness to perform effective contraceptive practices during treatment for patients with childbearing potential

Exclusion

  • Evidence of distant metastases (cM1)
  • Prior high-dose radiotherapy to the thorax or abdomen
  • Primary tumor cT4b
  • history or concurrent malignancy as judged by the treating physician. This is only an exclusion criterion if the other malignancy is considered the oncological potentially leading cause of death compared to the esophageal cancer.

Key Trial Info

Start Date :

December 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2029

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT06189898

Start Date

December 15 2023

End Date

January 31 2029

Last Update

January 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charité Universitätsmedizin Berlin

Berlin, Germany, 13353

Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study | DecenTrialz